| Item Type | Name |
|
Concept
|
Cell Line, Tumor
|
|
Academic Article
|
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
|
|
Academic Article
|
Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface.
|
|
Academic Article
|
An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis.
|
|
Academic Article
|
CD95 promotes tumour growth.
|
|
Academic Article
|
Let-7 expression defines two differentiation stages of cancer.
|
|
Academic Article
|
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.
|
|
Academic Article
|
Ligand-independent activation of c-Met by fibronectin and a(5)ß(1)-integrin regulates ovarian cancer invasion and metastasis.
|
|
Academic Article
|
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
|
|
Academic Article
|
The effects of 17ß-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
|
|
Academic Article
|
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.
|
|
Academic Article
|
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
|
|
Academic Article
|
Up-regulation of alpha5-integrin by E-cadherin loss in hypoxia and its key role in the migration of extravillous trophoblast cells during early implantation.
|
|
Academic Article
|
Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
|
|
Academic Article
|
miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin a5 expression.
|
|
Academic Article
|
MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer.
|
|
Academic Article
|
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.
|
|
Academic Article
|
Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype.
|
|
Academic Article
|
Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.
|
|
Academic Article
|
Epithelial ovarian cancer experimental models.
|
|
Academic Article
|
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
|
|
Academic Article
|
The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
|
|
Academic Article
|
Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
|
|
Academic Article
|
Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
|
|
Academic Article
|
Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.
|
|
Academic Article
|
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers.
|
|
Academic Article
|
Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
|
|
Academic Article
|
Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.
|
|
Academic Article
|
Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity.
|
|
Academic Article
|
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.
|
|
Academic Article
|
A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth.
|
|
Academic Article
|
A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.
|
|
Academic Article
|
An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells.
|
|
Academic Article
|
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer.
|
|
Academic Article
|
Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.
|
|
Academic Article
|
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.
|
|
Academic Article
|
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
|
|
Academic Article
|
Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.
|
|
Academic Article
|
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.
|
|
Academic Article
|
Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation.
|
|
Academic Article
|
Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.
|
|
Academic Article
|
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
|
|
Academic Article
|
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis.
|
|
Academic Article
|
Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.
|
|
Academic Article
|
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.
|